UNSPSC 51332401: Pentabamate

This classification denotes an antipsychotic agent with the molecular formula C8H16N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8871ZB4UGC, chemically known as 1,2,3-trimethyltrimethylenedicarbamate but generally known as pentabamate, which bears US NIH Compound Identifier 3047822. European Medicines Agency schedules Pentabamate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09674MIG.

UNSPSC 51332401 Pentabamate is a Commodity code that captures pharmaceutical and medical supply procurement, though the recent activity indexed under this code shows a mismatch with the nominal classification. The single recent solicitation recorded under the code—Seminole County, Florida's IFB60459723LAS for Naloxone and Safe Drug Deactivation Systems—reflects community health and emergency response supplies rather than pentabamate specifically. State and local procurement offices have not posted other opportunities under this code in the recent period, limiting visibility into the breadth of work actually being procured under the Pentabamate designation. The issuing body in the indexed record is a county health and procurement function, suggesting that pharmaceutical and medical-supply categories at the Commodity tier may see activity from county health departments and community health authorities.

Seminole County, Florida represents the sole geographic footprint supported by recent solicitation data for this code. Seminole County's IFB60459723LAS, posted June 30, 2026 with a response deadline of July 26, 2023, solicits 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract runs two years with a one-year renewal option, is potentially funded through FEMA, and requires bidders to submit unit pricing electronically through the county's e-Procurement Portal, include all shipping and delivery costs in proposals, and meet E-Verify and drug-free workplace certification requirements. The mismatch between the code name and the actual work solicited suggests that this Commodity code may see limited or sporadic state and local activity, or that indexing practice in the source system does not consistently align pharmaceutical SKUs to their intended UNSPSC classifications.